DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy

OBJECTIVE: This study aimed to develop a new oral paclitaxel formulation (DHP23002) and to evaluate its absorption and antitumor effects in a pancreatic tumor mouse model. METHODS: To investigate the oral absorption of DHP23002, a newly developed lipid-based orally active paclitaxel formulation, a p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Jang, Eunseo, Son, Minhee, Jang, Junhee, Lee, In-Hyun, Kim, Sol, Kwon, Taejun, Jeon, Yong-hyun, Koh, Woo-Suk, Kim, Kil-Soo, Kim, Sang Kyoon
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6863550/
https://ncbi.nlm.nih.gov/pubmed/31743348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0225095
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados